Drugs / SVF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05925829 | Jan → Dec 2017 | type 2 diabetes mellitus | Hayandra Peduli Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SVF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05925829 ↗ |
| Route | Intravenous | “The mixture of SVF and aaPRP was then infused intravenously to each patient for a duration of around 30 minutes.” NCT05925829 ↗ |